Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
AN ODE TO THE MUSHROOM by Paul Stamets
January 23, 2019
My Foot Fungus
January 23, 2019
Fungal Poems: Pourriture Noble BY MARIE PONSOT
January 23, 2019
Aspergillus in a well-loved pillow written by Caroline Hawkridge
January 23, 2019
Patients meeting November 2018
January 11, 2019
Patients meeting August 2018
January 11, 2019
Patients meeting July 2018
January 11, 2019
Patients meeting May 2018
January 11, 2019
Patients meeting April 2018
January 11, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video